STOCK TITAN

Eve Holding warrants halted for abnormally low price

The warrant action leaves EVEX common-stock trading unaffected, subject to the company’s continued compliance with other NYSE listing requirements.

(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Eve Holding, Inc. (EVEX) said the NYSE determined to begin delisting proceedings for its public warrants, EVEXW, and immediately suspend warrant trading, citing “abnormally low selling price” levels. The NYSE notified the company on October 21, 2026, and publicly announced the action on October 22, 2026. Each warrant is exercisable for one common share at an exercise price of $11.50 per share. The NYSE will apply to the SEC for delisting after applicable procedures are completed. Trading in EVEX common stock is unaffected and will continue on the NYSE, subject to the company’s continued compliance with other listing requirements.

Insights

Analyzing...

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Common shares exercisable per warrant 1 share Each public warrant is exercisable for one common share.
Warrant exercise price $11.50 per share Exercise price for each common share issuable upon warrant exercise.
delist regulatory
"commence proceedings to delist the Company’s public warrants"
Delist means a company’s shares are removed from a public stock exchange so they can no longer be bought or sold on that market. Think of it like a product being taken off a supermarket shelf: the stock becomes harder to find, often leads to less trading, wider price swings, and reduced transparency, which matters to investors because it can limit ability to sell, change the value of holdings, and signal regulatory or financial problems.
abnormally low selling price regulatory
"due to “abnormally low selling price” levels"
exercise price financial
"at an exercise price per share of $11.50"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did the NYSE suspend EVEXW trading?

The NYSE cited “abnormally low selling price” levels as the reason for immediately suspending trading in Eve Holding’s public warrants. The NYSE notified the company on October 21, 2026, and publicly announced the action on October 22, 2026.

Will the EVEX common stock be affected by the warrant delisting?

Trading in Eve Holding’s common stock will be unaffected by the warrant delisting and will continue on the NYSE under EVEX, subject to the company’s continued compliance with the NYSE’s other continued listing requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
0001823652 false00018236522026-10-212026-10-210001823652us-gaap:CommonStockMember2026-10-212026-10-210001823652us-gaap:WarrantMember2026-10-212026-10-21

0001823652 false 0001823652 us-gaap:CommonStockMember 2023-03-16 2023-03-16 0001823652 us-gaap:WarrantMember 2023-03-16 2023-03-16 0001823652 2023-03-16 2023-03-16UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): October 21, 2026

 

EVE HOLDING, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of incorporation)

 

 

 

 

 

001-39704

 

85-2549808

(Commission File Number)

 

(IRS Employer Identification No.)

 

 

 

 

 

1400 General Aviation Drive,

Melbourne, Florida

 

32935

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code (321)751-5050

 

N/A 

(Former name or former address, if changed since last report.) 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:

Trading Symbol:

Name of each exchange on which registered:

Common Stock, par value $0.001 per share

EVEX

The New York Stock Exchange

Warrants, each whole warrant exercisable for one share of Common Stock

EVEXW

The New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.  

 

On October 21, 2026, the New York Stock Exchange (the “NYSE”) notified Eve Holding, Inc. (the “Company”), and, on October 22, 2026, publicly announced, that the NYSE has determined to (a) commence proceedings to delist the Company’s public warrants which are traded under the ticker symbol “EVEXW” (the “Warrants”), and (b) immediately suspend trading in the Warrants due to “abnormally low selling price” levels pursuant to Section 802.01D of the NYSE Listed Company Manual. Each Warrant is presently exercisable for one share of the Company’s common stock at an exercise price per share of $11.50. To effect the delisting, the NYSE will apply to the Securities and Exchange Commission (the “SEC”) to delist the Warrants upon completion of all applicable procedures.

 

Trading in the Company’s common stock will be unaffected by the delisting of the Warrants and will continue on the NYSE under the symbol “EVEX,” subject to the Company’s continued compliance with the NYSE’s other continued listing requirements.

 


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

EVE HOLDING, INC.

 

Date: October 26, 2026

 

 

 By:

 

/s/ Eduardo Siffert Couto

 

 

 

 

 

Name:

 

Eduardo Siffert Couto

 

 

 

 

 

Title:

 

Chief Financial Officer

 


 

 

Filing Exhibits & Attachments

5 documents

Keep reading